SHANGHAI, Oct. 18,
2024 /PRNewswire/ -- 111, Inc. ("111" or the
"Company") (NASDAQ: YI), a leading tech-enabled healthcare platform
company committed to reshaping the value chain of healthcare
industry by digitally empowering the upstream and downstream in
China, today announced that it
will report its unaudited financial results for the third quarter
ended September 30, 2024, before the U.S. market opens
on Thursday, November 28, 2024.
111's management team will host an earnings conference call
at 7:30 AM U.S. Eastern Time on Thursday, November
28, 2024 (8:30 PM Beijing Time on the same day).
Details for the conference call are as follows:
Conference Topic: 111, Inc. Third Quarter 2024 Earnings
Conference Call
Registration
Link: https://s1.c-conf.com/diamondpass/10042738-te7sgd.html
All participants must use the link provided above to complete
the online registration process in advance of the conference call.
Upon registering, each participant will then be provided with the
dial in number, the Passcode, and your unique access PIN. This
information will also be emailed to you as a calendar invite.
Please dial in 15 minutes before the call is scheduled to begin.
To join the conference, simply dial the number in the calendar
invite and enter the passcode followed by your PIN, and you will
join the conference instantly.
A live and archived webcast of the conference call will be
available on the website
at https://edge.media-server.com/mmc/p/3nkscjv6
A telephone replay of the call will be available after the
conclusion of the conference call until December 5, 2024.
China: 4001209216
United States: +1-855-883-1031
International: +61-7-3107-6325
Conference ID: 10042738
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading
tech-enabled healthcare platform company committed to reshaping the
value chain of healthcare industry by digitally empowering the
upstream and downstream in China. The Company provides
consumers with better access to pharmaceutical products and
healthcare services directly through its online retail pharmacy, 1
Pharmacy, and indirectly through its offline virtual pharmacy
network. The Company also offers online healthcare services through
its internet hospital, 1 Clinic, which provides consumers with
cost-effective and convenient online consultation, electronic
prescription service, and patient management service. In addition,
the Company's online platform, 1 Medicine, serves as a one-stop
shop for pharmacies to source a vast selection of pharmaceutical
products. With the largest virtual pharmacy network in China,
111 enables offline pharmacies to better serve their customers with
cloud-based services. 111 also provides an omni-channel drug
commercialization platform to its strategic partners, which
includes services such as digital marketing, patient education,
data analytics, and pricing monitoring.
For more information on 111, please
visit: http://ir.111.com.cn/.
View original
content:https://www.prnewswire.com/news-releases/111-to-announce-third-quarter-2024-unaudited-financial-results-on-november-28-2024---conference-call-to-follow-302280169.html
SOURCE 111, Inc.